183 related articles for article (PubMed ID: 37845104)
1. Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group.
Kaplan MA; Şendur MAN; Cangır AK; Fırat P; Göker E; Kılıçkap S; Oyan B; Büge Öz A; Özdemir F; Özyiğit G
Curr Probl Cancer; 2023 Dec; 47(6):101017. PubMed ID: 37845104
[TBL] [Abstract][Full Text] [Related]
2. Leveraging the pleural space for anticancer therapies in pleural mesothelioma.
Blyth KG; Adusumilli PS; Astoul P; Darlison L; Lee YCG; Mansfield AS; Marciniak SJ; Maskell N; Panou V; Peikert T; Rahman NM; Zauderer MG; Sterman D; Fennell DA
Lancet Respir Med; 2024 Jun; 12(6):476-483. PubMed ID: 38740045
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitor therapy for malignant pleural mesothelioma.
Nowak AK; Chin WL; Keam S; Cook A
Lung Cancer; 2021 Dec; 162():162-168. PubMed ID: 34823106
[TBL] [Abstract][Full Text] [Related]
4. Advances in the treatment of malignant pleural mesothelioma.
Sterman DH; Kaiser LR; Albelda SM
Chest; 1999 Aug; 116(2):504-20. PubMed ID: 10453882
[TBL] [Abstract][Full Text] [Related]
5. What's the place of immunotherapy in malignant mesothelioma treatments?
Grégoire M
Cell Adh Migr; 2010; 4(1):153-61. PubMed ID: 20179421
[TBL] [Abstract][Full Text] [Related]
6. Approved and emerging treatments of malignant pleural mesothelioma in elderly patients.
Ceresoli GL; Rossi A
Expert Rev Respir Med; 2019 Dec; 13(12):1179-1188. PubMed ID: 31596154
[No Abstract] [Full Text] [Related]
7. The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma.
Paajanen J; Bueno R; De Rienzo A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362209
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for immunotherapy in malignant pleural mesothelioma?
Tartarone A; Lerose R; Aieta M
Med Oncol; 2018 May; 35(7):98. PubMed ID: 29845408
[TBL] [Abstract][Full Text] [Related]
9. Management of recurrence after initial surgery for malignant pleural mesothelioma: a mini-review.
Halezeroğlu S; Migliore M
Future Oncol; 2015; 11(24 Suppl):23-7. PubMed ID: 26638919
[TBL] [Abstract][Full Text] [Related]
10. Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement.
Assié JB; Jean D
Expert Opin Ther Targets; 2023; 27(11):1059-1069. PubMed ID: 37902459
[TBL] [Abstract][Full Text] [Related]
11. Malignant pleural mesothelioma.
Raja S; Murthy SC; Mason DP
Curr Oncol Rep; 2011 Aug; 13(4):259-64. PubMed ID: 21573909
[TBL] [Abstract][Full Text] [Related]
12. The evolution of multimodality therapy for malignant pleural mesothelioma.
Zauderer MG; Krug LM
Curr Treat Options Oncol; 2011 Jun; 12(2):163-72. PubMed ID: 21404104
[TBL] [Abstract][Full Text] [Related]
13. Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.
Dubois F; Bazille C; Levallet J; Maille E; Brosseau S; Madelaine J; Bergot E; Zalcman G; Levallet G
Target Oncol; 2022 Jul; 17(4):407-431. PubMed ID: 35906513
[TBL] [Abstract][Full Text] [Related]
14. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.
Carbone M; Adusumilli PS; Alexander HR; Baas P; Bardelli F; Bononi A; Bueno R; Felley-Bosco E; Galateau-Salle F; Jablons D; Mansfield AS; Minaai M; de Perrot M; Pesavento P; Rusch V; Severson DT; Taioli E; Tsao A; Woodard G; Yang H; Zauderer MG; Pass HI
CA Cancer J Clin; 2019 Sep; 69(5):402-429. PubMed ID: 31283845
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?
Agrawal A; Chaddha U; Shojaee S; Maldonado F
Semin Respir Crit Care Med; 2023 Aug; 44(4):462-467. PubMed ID: 37308112
[TBL] [Abstract][Full Text] [Related]
16. Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies.
Remon J; Reguart N; Corral J; Lianes P
Cancer Treat Rev; 2015 Jan; 41(1):27-34. PubMed ID: 25467107
[TBL] [Abstract][Full Text] [Related]
17. How I treat malignant pleural mesothelioma.
Viscardi G; Di Liello R; Morgillo F
ESMO Open; 2020 Mar; 4(Suppl 2):e000669. PubMed ID: 32156681
[TBL] [Abstract][Full Text] [Related]
18. [Malignant pleural mesothelioma in 1997].
Viallat JR; Boutin C; Kasseyet S
Schweiz Med Wochenschr; 1997 Oct; 127(41):1707-11. PubMed ID: 9441378
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream.
Calabrò L; Bronte G; Grosso F; Cerbone L; Delmonte A; Nicolini F; Mazza M; Di Giacomo AM; Covre A; Lofiego MF; Crinò L; Maio M
Front Immunol; 2023; 14():1333661. PubMed ID: 38259475
[TBL] [Abstract][Full Text] [Related]
20. The timing of chemotherapy in the management plan for medically operable early-stage malignant pleural mesothelioma.
Shohdy K; Abdel-Rahman O
Expert Rev Respir Med; 2019 Jun; 13(6):579-584. PubMed ID: 30977408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
